Bill Summary
SB 876 Chimeric Antigen Receptor T-cell Therapy (2025 Session)
Chimeric Antigen Receptor T-cell Therapy; Prohibiting health insurers and health maintenance organizations issuing, delivering, or renewing certain policies or contracts from refusing to contract with or denying coverage for certain providers of chimeric antigen receptor T-cell therapy, etc. Effective Date: 1/1/2026
02/19/25
SENATE
Filed
02/28/25
SENATE
Referred to Banking and Insurance; Judiciary; Rules
05/03/25
SENATE
Indefinitely postponed and withdrawn from consideration
06/16/25
SENATE
Died in Banking and Insurance
No amendments to this bill text filed.
627.64198
627.6614
641.31078
Revenue Estimating Coverence Reports, Veto, Transmittal letters and more. Learn more.
No reports related to this bill.
Florida's most comprehensive legislative calendar.
Learn more.
No events are scheduled at this time.
Related Press Announcements. Learn more.
No press releases related to this bill.
Features above are available to LobbyTools subscribers.
Request a free demo or call (850) 915-0100 ext. 2 to learn more.
